Following her election to the NBMTM’s Board of Directors in January 2022, Bhavana Mutha, Rph, BCMTMS, BCMAS, began her first 2-year term of service as Chair of Board of Directors. She leads the nine-member board, ensuring that the organization aims to advance the pharmacist profession.
Bhavana Mutha is an influential pharmacist leader with a mission to increase pharmacists’ involvement in direct patient care and spread the practice of medication therapy management. She is also a pioneer in pharmacogenomics and collaborative practice.
A sought-after speaker, Bhavana has delivered presentations for a diverse range of groups, domestic and international. She has served as a guest speaker for various pharmacy organizations and pharmacy schools worldwide. She hosted the first-ever “RxTEDx,” a TEDx event that exclusively celebrates pharmacists’ contributions to patient care.
Bhavana is the founder of RxCarePath, a company focused on value-based care programs that assist pharmacists in implementing pharmacogenomics into their collaborative care practice. She also serves as Director of Clinical Services for Genetic Technological Innovation (GTI), involving pharmacogenetic applications and antimicrobial stewardship. She also serves as an advisory board member of the nonprofit Pharmacist Moms’ organization, with over 45,000 pharmacists collaborating with Pharmacy Times.
Prior to her current role as chair of the NBMTM Board of Directors, she served as the chair of NBMTM’s examination advisory board. In addition, she contributed to the Pharmacy Quality Alliance (PQA) technical expert panel, education advisory council, and CPIQ innovation awards as a judge. Bhavana has over 20 years of experience as a pharmacist and held positions in CHC Health, Curant Health, and Adhere Health.
Bhavana received her B.S. in pharmacy from Government College of Pharmacy in Karad, India. She is board certified in medication therapy management and medical affairs. She is licensed in drug therapy modification (PDTM) in Georgia and sees patients through a collaborative practice agreement.